TRYPTOPHAN METABOLITE RATIO PHARMACOGENOMICS AND PHARMACOMETABOLOMICS: SOD2 AS A MARKER FOR SSRI RESPONSE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD).

D. Neavin, A. Taddei,B. Ray,J. Biernacka,H. Zhu,G. Jenkins, K. Kalari,T. Mushiroda,Y. Nakamura,M. Kubo,W. Matson, L. Wang, R. Kaddurah-Daouk, R. Weinshilboum

CLINICAL PHARMACOLOGY & THERAPEUTICS(2015)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要